Ajay Bhardwaj (#1755)
- $ 2 B
- Biopharma
- India
- M
- 65 Years
Rest in Peace Ask Jeeves, every search comes to an end
County commissioners call on lawmakers to up funding for 911 dispatch systems
Spirit Airlines Is Going Out Of Business; Effective IMMEDIATELY
Pokémon Scalpers Selling Limited-Edition Pop-Tarts For Ridiculous Prices
Bennett says Netanyahu gov't 'boycotting' West Bank settlements amid Carrefour subsidy deal
Golf gear on sale now: Up to 65% off adidas, 45% off Puma, 15% off Mizuno, more
Families across the US can't find childcare — this map shows where it's worst
Median sales surge 61% in a Queens neighborhood that’s now the fifth priciest in NYC
Greg Brockman says his stake in OpenAI is worth nearly $30 billion
TeraWulf Announces Participation in Upcoming Investor and Industry Conferences
About Me
Chairman and managing director of biotech company Anthem Biosciences which he cofounded in 2006 in Bangalore. Anthem Biosciences is involved in drug discovery and development as well as contract manufacturing of specialised ingredients such as enzymes and peptides for pharma and biotech companies. Anthem went public in Juiy 2025 and its stock was listed at a 27% premium to the issue price. Bhardwaj has four decades of experience in the life sciences sector, including a long stint as president at fellow billionaire Kiran Mazumdar-Shaw's Biocon. His son Ishaan works at the company as a vice president.
Achievements
Career Highlights
A snapshot of the defining milestones, leadership decisions, and breakthroughs that shaped Ajay Bhardwaj’s rise and global influence.
Wealth Growth
Net Worth Growth Over Time
Tracking Ajay Bhardwaj’s net worth journey over the years, highlighting key growth phases and financial milestones.
© Iconic Billionaires